Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.6%

25 terminated/withdrawn out of 330 trials

Success Rate

88.8%

+2.3% vs industry average

Late-Stage Pipeline

10%

33 trials in Phase 3/4

Results Transparency

33%

65 of 199 completed trials have results

Key Signals

41 recruiting65 with results12 terminated13 withdrawn

Enrollment Performance

Analytics

N/A
180(67.2%)
Phase 2
37(13.8%)
Phase 4
23(8.6%)
Phase 1
17(6.3%)
Phase 3
10(3.7%)
Early Phase 1
1(0.4%)
268Total
N/A(180)
Phase 2(37)
Phase 4(23)
Phase 1(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (330)

Showing 20 of 330 trials
NCT06182475Not ApplicableNot Yet Recruiting

Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3

Role: lead

NCT02456090Active Not Recruiting

PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care

Role: collaborator

NCT06854120Recruiting

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

Role: collaborator

NCT04097158Recruiting

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Role: collaborator

NCT05033990Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

Role: collaborator

NCT03510351Completed

Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

Role: lead

NCT03903120Phase 1Completed

ASSIST: Treatment for Childhood Apraxia of Speech

Role: lead

NCT05966038Recruiting

ALS/MND Natural History Study Data Repository

Role: collaborator

NCT07589764Phase 1Not Yet Recruiting

A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

Role: collaborator

NCT07432555Not ApplicableNot Yet Recruiting

Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System

Role: lead

NCT03865927Phase 2Completed

GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis

Role: collaborator

NCT02714257Not ApplicableCompleted

Working to Increase Stability Through Exercise

Role: collaborator

NCT02968212Phase 2Active Not Recruiting

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Role: collaborator

NCT07027865Not ApplicableCompleted

Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents

Role: lead

NCT05766384Recruiting

Hyperpolarized 129Xe MRI Lung Health Cohort

Role: collaborator

NCT06257446Not ApplicableCompleted

InformationSeekingMesolimbicEngagementStudy1

Role: lead

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT05195918Phase 1Completed

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Role: collaborator

NCT07340580Not ApplicableNot Yet Recruiting

Implementation Facilitation of Exercise is Medicine Greenville

Role: collaborator

NCT07505121Not ApplicableNot Yet Recruiting

Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.

Role: lead